Dysexecutive symptoms in substance abusers under treatment using the Spanish version of the dysexecutive questionnaire (DEX-Sp);Sintomatología disejecutiva en adictos a sustancias en tratamiento mediante la versión española del cuestionario disejecutivo (DEX-Sp)

Revista de Neurologia

Volumn 47, Issue 9, 2008, Pages 457-463

  Llanero Luque, M ^a   Ruiz Sanchez De Leon J M ^a   Pedrero Perez E J ^b   Olivar Arroyo, A ^c   Bouso Saiz, J C ^d   Rojo Mota, G ^b   Puerta García, Carmen ^b,e  

^a Centro de Prevencion del Deterioro Cognitivo   (Spain)

^b Centro de Atención A Drogodependientes CAD 4   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e Centro de Atención a Drogodependientes CAD 4 San Blas   (Spain)

Author keywords

Addiction; DEX; Drug abuse; Drug addiction; Dysexecutive syndrome; Executive functions; Frontal cortex; Frontal lobes; Neuropsychology; Screening

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CONTROL GROUP; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; QUESTIONNAIRE; SCREENING; SUBSTANCE ABUSE; SYMPTOMATOLOGY;

EID: 56049112365     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4709.2008257     Document Type: Article

References (57)

1. Muñoz-Céspedes JM, Tirapu-Ustárroz J. Rehabilitación de las funciones ejecutivas. Rev Neurol 2004; 38: 656-63.
2. Tirapu-Ustárroz J, Muñoz-Céspedes JM, Pelegrín-Valero C. Funciones ejecutivas: necesidad de una integración conceptual. Rev Neurol 2002; 34: 673-85.
3. Papazian O, Alfonso I, Luzondo RJ. Trastornos de las funciones ejecutivas. Rev Neurol 2006; 42 (Supl 3): S45-50.
4. Jódar-Vicente M. Funciones cognitivas del lóbulo frontal. Rev Neurol 2004; 39: 178-82.
5. Estévez-González A, García-Sánchez C, Barraquer-Bordas LL. Los lóbulos frontales: el cerebro ejecutivo. Rev Neurol 2000; 31: 566-77.
6. Tirapu-Ustárroz J, García-Molina A, Luna-Lario P, Roig-Rovira T, Pelegrín-Valero C. Modelos de funciones y control ejecutivo (I). Rev Neurol 2008; 46: 684-92.
7. Tirapu-Ustárroz J, García-Molina A, Luna-Lario P, Roig-Rovira T, Pelegrín-Valero C. Modelos de funciones y control ejecutivo (II). Rev Neurol 2008; 46: 742-50.
8. Rebollo MA, Montiel S. Atención y funciones ejecutivas. Rev Neurol 2006; 42 (Supl 2): S3-7.
9. Fishbein DH, Krupitsky E, Flannery BA, Langevin DJ, Bobashev G, Verbitskaya E, et al. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend 2007; 90: 25-38.
10. Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 2006; 84: 240-7.
11. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 2004; 24: 11017-22.
12. Schilt T, de Win MML, Koeter M, Jager G, Korf DJ, van den Brink W, et al. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry 2007; 64: 728-36.
13. Giancola PR, Mezzich AC. Executive functioning, temperament, and drug use involvement in adolescent females with a substance use disorder. J Child Psychol Psychiatry 2003; 44: 857-66.
14. Verdejo A, Pérez-García M. Ecological assessment of executive functions in substance dependent individuals. Drug Alcohol Depend 2007; 90: 48-55.
15. Verdejo A, Orozco-Giménez C, Meersmans M, Aguilar de Arcos F, Pérez-García M. Impacto de la gravedad del consumo de drogas sobre distintos componentes de la función ejecutiva. Rev Neurol 2004; 38: 1109-16.
16. Malloy P, Grace JA. A review of rating scales for measuring behavior change due to frontal systems damage. Cog Behav Neurol 2005; 18: 18-27.
17. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural assessment of the dysexecutive syndrome. Bury St. Edmunds, UK: Thames Valley Test; 1996.
18. Grace J, Malloy PF. Frontal Systems Behavior Scale (FrSBe): professional manual. Lutz, FL: Psychological Assessment Resources; 2001.
19. Gioia GA, Isquith PK, Guy SC, Kenworthy L. The behavior rating inventory of executive function professional manual. Odessa, FL: Psychological Assessment Resources; 2000.
20. Barrash J, Tranel D, Anderson SW. Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region. Dev Neuropsychol 2000; 18: 355-81.
21. Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997; 24: 29-36.
22. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-14.
23. Burgess PW, Alderman N, Evans J, Emslie H, Wilson B. The ecological validity of tests of executive function. J Int Neuropsychol Soc 1998; 4: 547-58.
24. Amieva H, Phillips L, Della Sala S. Behavioral dysexecutive symptoms in normal aging. Brain Cogn 2003; 53: 129-32.
25. Chan RCK. Dysexecutive symptoms among a non-clinical sample: a study with the use of the Dysexecutive Questionnaire. Br J Psychol 2001; 92: 551-65.
26. Chan RCK, Hoosain R, Lee TMC. Reliability and validity of the Cantonese version of the test of everyday attention among normal Hong Kong Chinese: a preliminary report. Clin Rehabil 2002; 16: 900-9.
27. Wang Y, Chan RCK, Deng YY. Examination of postconcussion-like symptoms in healthy college students: relationships to subjective and objective neuropsychological function performance. Arch Clin Neuropsychol 2006; 21: 339-47.
28. Mooney B, Walmsley C, McFarland K. Factor analysis of the self-report Dysexecutive (DEX-S) Questionnaire. Appl Neuropsychol 2006; 13: 12-8.
29. Walley RM, Donaldson MD. An investigation of executive function abilities in adults with Prader-Willi syndrome. J Intellect Disabil Res 2005; 49: 613-25.
30. Mathias JL. Neurobehavioral functioning of persons with Parkinson's disease. Appl Neuropsychol 2003; 10: 57-68.
31. Cullen B, Coen RF, Lynch CA, Cunningham CJ, Coakley D, Robertson IH, et al. Repetitive behaviour in Alzheimer's disease: description, correlates and functions. Int J Geriatr Psychiatry 2005; 20: 686-93.
32. Alderman N, Dawson K, Rutterford NA, Reynolds PJ. A comparison of the validity of self-report measures amongst people with acquired brain injury: a preliminary study of the usefulness of EuroQol-5D. Neuropsychol Rehabil 2001; 11: 529-37.
33. Hart T, Whyte J, Kim J, Vaccaro M. Executive function and self-awareness of real-world behavior and attention deficits following traumatic brain injury. J Head Trauma Rehabil 2005; 20: 333-47.
34. Larson MJ, Perlstein WM, Demery JA, Stigge-Kaufman DA. Cognitive control impairments in traumatic brain injury. J Clin Exp Neuropsychol 2006; 28: 968-86.
35. Wood RL, Liossi C. The ecological validity of executive tests in a severely brain injured sample. Arch Clin Neuropsychol 2006; 21: 429-37.
36. Chaytor N, Schmitter-Edgecombe M, Burr R. Improving the ecological validity of executive functioning assessment. Arch Clin Neuropsychol 2006; 21: 217-27.
37. Heffernan T, Ling J, Bartholomew J. Self-rated prospective memory and central executive deficits in excessive alcohol users. Irish J Psychol Med 2004; 21:122-4.
38. Whitney P, Hinson JM, Jameson TL. From executive control to self-control: predicting problem drinking among college students. Appl Cogn Psychol 2006; 20: 823-35.
39. Reay JL, Hamilton C, Kennedy DO, Scholey AB. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgment processes. J Psychopharmacol 2006; 20: 385-8.
40. Hinson JM, Jameson TL, Whitney P. Impulsive decision making and working memory. J Exp Psychol 2003; 29: 298-306.
41. Verdejo A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008; 32: 777-810.
42. Goodman L. Snowball sampling. Ann Math Stat 1961; 32: 148-70.
43. Pedrero-Pérez E, Ruiz-Sánchez de León JM, Olivar-Arroyo A, Bouso-Saiz JC, Rojo-Mota G, Llanero-Luque M, et al. Spanish version of the Dysexecutive Questionnaire (DEX-Sp): psychometric properties in addicts and non-clinical sample. J Int Neuropsychol Soc 2008 [submitted].
44. Corominas M, Roncero C, Bruguera E, Casas, M. Sistema dopaminérgico y adicciones. Rev Neurol 2007; 44: 23-31.
45. Puerta C. Trastornos de personalidad asociados a adicciones y diferencias de género. Ponencia en el III Simposio Nacional de Adicción en la Mujer. Madrid: Fundación Spiral; 2007. URL: http://www.institutospiral. com/IIIsymposium/index.htm. [20.04.2008].
46. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 2001; 39: 376-89.
47. Bechara A, Dolan S, Hindes A. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 2002; 40: 1690-705.
48. Verdejo A, Aguilar de Arcos F, Pérez-García M. Alteraciones de los procesos de toma de decisiones vinculados al córtex prefrontal ventromedial en pacientes drogodependientes. Rev Neurol 2004; 38: 601-6.
49. Pedrero-Pérez EJ. Temperamento, carácter y trastornos de la personalidad. Aplicación del TCI-R a una muestra de consumidores de drogas en tratamiento y su relación con el MCMI-II. Adicciones 2006; 18: 135-48.
50. Tirapu-Ustárroz J, Muñoz-Céspedes JM. Memoria y funciones ejecutivas. Rev Neurol 2005; 41: 475-84.
51. Heinz A. Disfunción dopaminérgica en el alcoholismo y la esquizofrenia: correlatos psicopatológicos y conductuales. Eur Psychiatry (ed. esp.). 2002; 9: 238-46.
52. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol 2003; 54: 25-53.
53. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006; 81: 313-22.
54. Teichner G, Horner MD, Roitzsch JC, Herron J, Thevos A. Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict Behav 2002; 27: 751-63.
55. Yücel M, Lubman DI, Solowij N, Brewer WJ. Understanding drug addiction: a neuropsychological perspective. Aust N Z J Psychiatry 2007; 41: 957-68.
56. Dinn WM, Aycicegi A, Harris CL. Cigarette smoking in a student sample: Neurocognitive and clinical correlates. Addict Behav 2004; 29: 107-26.
57. Lorea-Conde I, Tirapu-Ustárroz J, Landa N, López-Goñi JJ. Deshabituación de drogas y funcionamiento cerebral: una visión integradora. Adicciones 2005; 17: 121-9.